1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Radiopharmaceuticals Market – By Type

1.3.2        North America Radiopharmaceuticals Market – By Application

1.3.3        North America Radiopharmaceuticals Market – By End User

1.3.4        North America Radiopharmaceuticals Market– By Country

2.           Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Radiopharmaceuticals Market– Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Experts Opinion

5.           North America Radiopharmaceuticals Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Felicity of Alpha Radio Immunotherapy in Targeted Cancer Treatment

5.1.2        Growing Advancements in Nuclear Imaging Techniques

5.2         Market Restraints

5.2.1        Presence of Substitutes

5.3         Market Opportunities

5.3.1        Growth Potential in Several Countries

5.4         Future Trends

5.4.1        Rising Use of Nuclear Medicines for Personalized Treatment

5.5         Impact Analysis

6.           Radiopharmaceuticals Market– North America Analysis

6.1         North America Radiopharmaceuticals Market Revenue Forecast and Analysis

7.           North America Radiopharmaceuticals Market Analysis – By Type

7.1         Overview

7.2         North America Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

7.3         Diagnostic Nuclear Medicine

7.3.1        Overview

7.3.2        Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3        SPECT

7.3.3.1          Overview

7.3.3.2          SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4        PET

7.3.4.1          Overview

7.3.4.2          PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Therapeutic Nuclear Medicine

7.4.1        Overview

7.4.2        Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3        Alpha Emitters

7.4.3.1          Overview

7.4.3.2          Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4        Beta Emitters

7.4.4.1          Overview

7.4.4.2          Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5        Brachytherapy Isotopes

7.4.5.1          Overview

7.4.5.2          Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.           North America Radiopharmaceuticals Market Analysis – By Application

8.1         Overview

8.2         North America Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

8.3         Oncology

8.3.1        Overview

8.3.2        Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Cardiology

8.4.1        Overview

8.4.2        Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Neurology

8.5.1        Overview

8.5.2        Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.           North America Radiopharmaceuticals Market Analysis – By End User

9.1         Overview

9.2         North America Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Imaging Centres

9.4.1        Overview

9.4.2        Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Academic and Research Centers

9.5.1        Overview

9.5.2        Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Others

9.6.1        Overview

9.6.2        Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10.        North America Radiopharmaceuticals Market – Country Analysis

10.1      North America: Radiopharmaceuticals Market

10.1.1     Overview

10.1.2     North America: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

10.1.2.1       US: Radiopharmaceuticals Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1       US: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2       US: Radiopharmaceuticals Market, by Type, 2019–2028 (USD Million)

10.1.2.1.2.1     US: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.2.2     US: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.3       US: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.1.4       US: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.2       Canada: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1       Canada: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2       Canada: Radiopharmaceuticals Market, by Type, 2019–2028 (USD Million)

10.1.2.2.2.1     North America: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.2.2     North America: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.3       Canada: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.2.4       Canada: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.3       Mexico: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1       Mexico: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2       Mexico: Radiopharmaceuticals Market, by Type – 2019–2028 (USD Million)

10.1.2.3.2.1     Mexico: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.2.2     Mexico: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.3       Mexico: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.3.4       Mexico: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11.        Impact Of COVID-19 Pandemic on North America Radiopharmaceuticals Market

11.1      North America: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Inorganic Growth Strategies

12.2.1     Overview

12.3      Organic Growth Strategies

12.3.1     Overview

13.        Company Profiles

13.1      Cardinal Health Inc

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Curium

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      GENERAL ELECTRIC

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Lantheus Medical Imaging, Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Bayer AG

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Bracco Imaging S.p.A

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      ECZACIBAI MONROL NUCLEAR PRODUCTS CO.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Nordion

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      NTP RADIOISOTOPES

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Advanced Accelerator Applications

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

Table 1.             North America Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Table 2.             US Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             US Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 4.             US Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 5.             US Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 6.             US Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 7.             Canada Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             North America Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 9.             North America Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 10.          Canada Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 11.          Canada Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12.          Mexico Radiopharmaceuticals Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 13.          Mexico Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 14.          Mexico Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 15.          Mexico Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16.          Mexico Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 17.          Recent Inorganic Growth Strategies

Table 18.          Recent Organic Growth Strategies

Table 19.          Glossary of Terms

Figure 1.           North America Radiopharmaceuticals Market Segmentation

Figure 2.           North America Radiopharmaceuticals Market Segmentation, By Country

Figure 3.           North America Radiopharmaceuticals Market Overview

Figure 4.           Diagnostic Nuclear Medicine Segment Held the Largest Share of the Market in 2021

Figure 5.           The US to Show Significant Growth During Forecast Period

Figure 6.           North America PEST Analysis

Figure 7.           North America Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints

Figure 8.           North America Radiopharmaceuticals Market– Revenue Forecast and Analysis

Figure 9.           North America Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

Figure 10.        North America Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        North America SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        North America PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        North America Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        North America Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        North America Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        North America Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        North America Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

Figure 18.        North America Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        North America Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        North America Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        North America Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        North America Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)

Figure 23.        North America Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        North America Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        North America Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        North America Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        North America: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)

Figure 28.        North America: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

Figure 29.        US: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        Canada: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.        Mexico: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 32.        Impact of COVID-19 Pandemic in North American Country Markets